Nigeria - English - NAFDAC (National Agency for Food and Drugs Administration and Control)

vi polysaccharide of salmonella typhi 25mcg

Nigeria - English - NAFDAC (National Agency for Food and Drugs Administration and Control)

vipoly saccharide of salmonella typhi 2ug

Philippines - English - FDA (Food And Drug Administration)

glaxosmithkline phils., inc. - typhoid vaccine (vi capsular polysaccharide) - solution for injection (im) - 25 mcg/0.5 ml

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

glaxosmithkline (gsk) - typhoid ty21a live attenuated - solution for injection in pre-filled syringe - 25 µg

Namibia - English - Namibia Medicines Regulatory Council

glaxosmithkline south africa (pty) ltd - typhoid fever vaccine - injection - each 0,5ml dose contains salmonella typhi 25,0?g

Ireland - English - HPRA (Health Products Regulatory Authority)

glaxosmithkline (ireland) limited - hepatit a virus antigen, vi polysaccharide of salmonella typhi - suspension for injection - %v/v - bacterial and viral vaccines, combined

New Zealand - English - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - hepatitis a vaccine 1440 eu/ml (virus antigen (hm175 strain)); vi capsular polysaccharide of s. typhi ty2 25 µg/ml;   - suspension for injection - active: hepatitis a vaccine 1440 eu/ml (virus antigen (hm175 strain)) vi capsular polysaccharide of s. typhi ty2 25 µg/ml   excipient: aluminium hydroxide amino acids formaldehyde neomycin sulfate polysorbate 20 sodium chloride trometamol water for injection - hepatyrix is indicated for active immunisation of adults and adolescents older than 15 years of age at risk of both hepatitis a virus infection and typhoid fever. immunisation with hepatyrix is particularly recommended in subjects who are, or will be, at increased risk of infection such as travellers from countries of low endemicity to areas where the prevalence of hepatitis a and typhoid fever is high.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

glaxosmithkline uk ltd - salmonella typhi (ty2 strain) vi capsular polysaccharide; hepatitis a virus (hm175 strain) inactivated - suspension for injection

Ireland - English - HPRA (Health Products Regulatory Authority)

ucb pharma limited - typhoid vaccine -

Israel - English - Ministry of Health

glaxo smith kline (israel) ltd - salmonela typhi vi polysaccharide 25 mcg / 0.5 ml - solution for injection - typhoid, purified polysaccharide antigen - active immunisation against typhoid fever, for adults and children older than two years of age.